Table 4.
Characteristics of five cases of primary varicella-zoster virus infection in pregnant women who received VZIG after exposure to varicella-zoster virus
| Case no. | |||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| Maternal age, yr | 23 | 28 | 37 | 31 | 36 |
| Nationality | Romania | Ukraine | Sweden | New Zealand (raised in Denmark) | Puerto Rico |
| Parity | 2nd para | 2nd para | 2nd para | 2nd para | 2nd para |
| Number of siblings | 0 | 1 | 2 | 3 | 2 |
| Smoking | Smoked during pregnancy | Never smoked | Never smoked | Never smoked | Previous smoker |
| Other diseases | None | Hepatitis B | None | None | None |
| Year of exposure | 2015 | 2014 | 2013 | 2012 | 2014 |
| Trimester | 2 | 2 | 3 | 3 | 3 |
| Source of exposure | Own child | Own child | Own child | Own child | Own child |
| Time from exposure to VZIG administration | 0 days | 5 days | 1 day | 7 days | 4 days |
| Severity of infection | <100 vesicles No pneumonia | <100 vesicles No pneumonia | Only a few vesicles No pneumonia | >100 vesicles No pneumonia | <100 vesicles No pneumonia |
| Admitted to hospital | No | No | No | Yes | Yes |
VZIG, Varicella-zoster immunoglobulin.